Batavia Biosciences is your CDMO partner for viral vectors for vaccines, gene therapy, or oncolytic virus and for proteins and antibodies. We're a centre of excellence in bioprocess development and GMP manufacturing. We aim to contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicine from discovery to clinic.
We offer our novel technologies and in depth know-how to help our partners to successfully complete preclinical phases in development at higher speed and reduced cost. Batavia focuses on the early stages of development including cell line generation, USP and DSP development, product characterization and clinical manufacturing.